Top compounds associated with response to POMZP3


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.005
mRNA 968 CTRPv2 pan-cancer AAC 0.19 0.005
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.12 0.005
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.005
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.089 0.008
mRNA BRD-K34485477 CTRPv2 pan-cancer AAC 0.2 0.008
mRNA HLI 373 CTRPv2 pan-cancer AAC 0.095 0.008
mRNA PD318088 CTRPv2 pan-cancer AAC -0.093 0.009
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.095 0.009
mRNA ciclosporin CTRPv2 pan-cancer AAC 0.1 0.009
Download CSV